m-Cumenyl methylcarbamate
Common Name: |
m-Cumenyl methylcarbamate |
IUPAC Name: |
(3-propan-2-ylphenyl) N-methylcarbamate |
Molecular Formula: |
C11H15NO2 |
SMILES: |
CC(C)C1=CC(=CC=C1)OC(=O)NC |
Inchi: |
1S/C11H15NO2/c1-8(2)9-5-4-6-10(7-9)14-11(13)12-3/h4-8H,1-3H3,(H,12,13) |
Inchi Key: |
GYKXQTKSWLAUIT-UHFFFAOYSA-N |
Cas No: |
64-00-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
193.24 |
Mass (g/mol) |
193.11 |
Molar Refractivity |
55.71 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
38.33 |
Hetero Atoms |
3 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
72 to 74 |
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.36 |
LogP |
2.528 |
iLOGP |
2.50 |
XLOGP3 |
2.63 |
WLOGP |
2.53 |
MLOGP |
2.37 |
ESOL Log S |
-2.75 |
ESOL Solubility (mg/ml) |
0.345 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.09 |
Ali Solubility (mg/ml) |
0.16 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.35 |
Silicos-IT Solubility (mg/ml) |
0.09 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.61 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.894 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.59 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |